Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Review Article

Comprehensive Perspectives for Erectile Dysfunction Pharmacotherapy: From Mechanism to Application

Author(s): Haibao Zhang, Guodong Zhu*, Haomin Ren, Wenbin Song and Zhishang Yang

Volume 29, Issue 41, 2022

Published on: 20 August, 2022

Page: [6276 - 6287] Pages: 12

DOI: 10.2174/0929867329666220613125000

Price: $65

Abstract

In recent years, the incidence of erectile dysfunction (ED) has continued to rise worldwide. Since pharmacotherapy is still the most common and effective method for the treatment of ED at present, many methods and drugs have been designed or developed for the treatment of ED. Oral phosphodiesterase-5 inhibitors and androgen supplement therapy are currently the common therapeutics for ED; however, some patients have poor responses to these drugs because of the multiple pathogenic mechanisms of ED. Researchers are trying to find other treatment ways. On the one hand, many new strategies and concepts, such as targeted therapy, are also integrated into clinical or preclinical research; on the other hand, some combined therapies that have synergistic effects with a reduced dose of a single drug and less adverse effects are also developed. This review article summarized the efficacy of the latest first-line, second-line drugs and adjuvant therapies for the treatment of ED, as well as the application of comprehensive treatments, which will help doctors not only deeply understand the mechanism of ED but select the suitable therapeutics for those patients.

Keywords: Erectile dysfunction, pharmacotherapy, drugs, treatment, comprehensive, effect, sexual intimacy.

[1]
Shamloul, R.; Ghanem, H. Erectile dysfunction. Lancet, 2013, 381(9861), 153-165.
[http://dx.doi.org/10.1016/S0140-6736(12)60520-0] [PMID: 23040455]
[2]
Li, T.; Wu, C.; Fu, F.; Qin, F.; Wei, Q.; Yuan, J. Association between use of aspirin or non-aspirin non-steroidal anti-inflammatory drugs and erectile dysfunction: A systematic review. Medicine (Baltimore), 2018, 97(28), e11367.
[http://dx.doi.org/10.1097/MD.0000000000011367] [PMID: 29995772]
[3]
Prakash, O.; Rao, T.S. Sexuality research in India: An update. Indian J. Psychiatry, 2010, 52(7), S260-S263.
[http://dx.doi.org/10.4103/0019-5545.69243] [PMID: 21836690]
[4]
Zhang, K.; Yu, W.; He, Z.J.; Jin, J. Help-seeking behavior for erectile dysfunction: A clinic-based survey in China. Asian J. Androl., 2014, 16(1), 131-135.
[http://dx.doi.org/10.4103/1008-682X.122350] [PMID: 24369146]
[5]
El-Sakka, A.I. Pharmacotherapy for erectile dysfunction in diabetic males. Expert Opin. Pharmacother., 2018, 19(12), 1345-1356.
[http://dx.doi.org/10.1080/14656566.2018.1505866] [PMID: 30106605]
[6]
Feldman, H.A.; Goldstein, I.; Hatzichristou, D.G.; Krane, R.J.; McKinlay, J.B. Impotence and its medical and psychosocial correlates: Results of the massachusetts male aging study. J. Urol., 1994, 151(1), 54-61.
[http://dx.doi.org/10.1016/S0022-5347(17)34871-1] [PMID: 8254833]
[7]
Zhang, X.; Yang, B.; Li, N.; Li, H. Prevalence and risk factors for erectile dysfunction in Chinese adult males. J. Sex. Med., 2017, 14(10), 1201-1208.
[http://dx.doi.org/10.1016/j.jsxm.2017.08.009] [PMID: 28874333]
[8]
Grossmann, M.; Matsumoto, A.M. A perspective on middle-aged and older men with functional hypogonadism: Focus on holistic management. J. Clin. Endocrinol. Metab., 2017, 102(3), 1067-1075.
[http://dx.doi.org/10.1210/jc.2016-3580] [PMID: 28359097]
[9]
Klein, R.; Klein, B.E.; Lee, K.E.; Moss, S.E.; Cruickshanks, K.J. Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care, 1996, 19(2), 135-141.
[http://dx.doi.org/10.2337/diacare.19.2.135] [PMID: 8718433]
[10]
Khoo, J.; Piantadosi, C.; Worthley, S.; Wittert, G.A. Effects of a low-energy diet on sexual function and lower urinary tract symptoms in obese men. Int. J. Obes., 2010, 34(9), 1396-1403.
[http://dx.doi.org/10.1038/ijo.2010.76] [PMID: 20404829]
[11]
McWaine, D.E.; Procci, W.R. Drug-induced sexual dysfunction. Med. Toxicol. Adverse Drug Exp., 1988, 3(4), 289-306.
[PMID: 3054427]
[12]
Defade, B.P.; Carson, C.C., III; Kennelly, M.J. Postprostatectomy erectile dysfunction: The role of penile rehabilitation. Rev. Urol., 2011, 13(1), 6-13.
[PMID: 21826123]
[13]
Yassin, A.A.; Saad, F. Testosterone and erectile dysfunction. J. Androl., 2008, 29(6), 593-604.
[http://dx.doi.org/10.2164/jandrol.107.004630] [PMID: 18641415]
[14]
Travison, T.G.; Shabsigh, R.; Araujo, A.B.; Kupelian, V.; O’Donnell, A.B.; McKinlay, J.B. The natural progression and remission of erectile dysfunction: Results from the massachusetts male aging study. J. Urol., 2007, 177(1), 241-246.
[http://dx.doi.org/10.1016/j.juro.2006.08.108] [PMID: 17162054]
[15]
Kouidrat, Y.; Pizzol, D.; Cosco, T.; Thompson, T.; Carnaghi, M.; Bertoldo, A.; Solmi, M.; Stubbs, B.; Veronese, N. High prevalence of erectile dysfunction in diabetes: A systematic review and meta-analysis of 145 studies. Diabet. Med., 2017, 34(9), 1185-1192.
[http://dx.doi.org/10.1111/dme.13403] [PMID: 28722225]
[16]
Hannan, J.L.; Blaser, M.C.; Oldfield, L.; Pang, J.J.; Adams, S.M.; Pang, S.C.; Adams, M.A. Morphological and functional evidence for the contribution of the pudendal artery in aging-induced erectile dysfunction. J. Sex. Med., 2010, 7(10), 3373-3384.
[http://dx.doi.org/10.1111/j.1743-6109.2010.01920.x] [PMID: 20584117]
[17]
Ferrini, M.G.; Kovanecz, I.; Sanchez, S.; Vernet, D.; Davila, H.H.; Rajfer, J.; Gonzalez-Cadavid, N.F. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat. Biol. Reprod., 2007, 76(5), 915-923.
[http://dx.doi.org/10.1095/biolreprod.106.059642] [PMID: 17287493]
[18]
Gruenwald, I.; Appel, B.; Vardi, Y. Low-intensity extracorporeal shock wave therapy-a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J. Sex. Med., 2012, 9(1), 259-264.
[http://dx.doi.org/10.1111/j.1743-6109.2011.02498.x] [PMID: 22008059]
[19]
Feng, Y.; LoGrasso, P.V.; Defert, O.; Li, R. Rho Kinase (ROCK) inhibitors and their therapeutic potential. J. Med. Chem., 2016, 59(6), 2269-2300.
[http://dx.doi.org/10.1021/acs.jmedchem.5b00683] [PMID: 26486225]
[20]
El-Sakka, A.I.; Lue, T.F. Physiology of penile erection. Sci. World J., 2004, 4(Suppl. 1), 128-134.
[http://dx.doi.org/10.1100/tsw.2004.58] [PMID: 15349538]
[21]
Yavuzgil, O.; Altay, B.; Zoghi, M.; Gürgün, C.; Kayikçioğlu, M.; Kültürsay, H. Endothelial function in patients with vasculogenic erectile dysfunction. Int. J. Cardiol., 2005, 103(1), 19-26.
[http://dx.doi.org/10.1016/j.ijcard.2004.07.004] [PMID: 16061118]
[22]
Foresta, C.; Caretta, N.; Lana, A.; Cabrelle, A.; Palù, G.; Ferlin, A. Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int. J. Impot. Res., 2005, 17(3), 288-290.
[http://dx.doi.org/10.1038/sj.ijir.3901311] [PMID: 15729373]
[23]
Dean, R.C.; Lue, T.F. Physiology of penile erection and pathophysiology of erectile dysfunction. Urol. Clin. North Am., 2005, 32(4), 379-395.
[http://dx.doi.org/10.1016/j.ucl.2005.08.007] [PMID: 16291031]
[24]
Peak, T.C.; Yafi, F.A.; Sangkum, P.; Hellstrom, W.J. Emerging drugs for the treatment of erectile dysfunction. Expert Opin. Emerg. Drugs, 2015, 20(2), 263-275.
[http://dx.doi.org/10.1517/14728214.2015.1021682] [PMID: 25740087]
[25]
Gur, S.; Kadowitz, P.J.; Hellstrom, W.J. Exploring the potential of NO-independent stimulators and activators of soluble guanylate cyclase for the medical treatment of erectile dysfunction. Curr. Pharm. Des., 2010, 16(14), 1619-1633.
[http://dx.doi.org/10.2174/138161210791164162] [PMID: 20201788]
[26]
Sopko, N.A.; Hannan, J.L.; Bivalacqua, T.J. Understanding and targeting the Rho kinase pathway in erectile dysfunction. Nat. Rev. Urol., 2014, 11(11), 622-628.
[http://dx.doi.org/10.1038/nrurol.2014.278] [PMID: 25311680]
[27]
Guagnini, F.; Ferazzini, M.; Grasso, M.; Blanco, S.; Croci, T. Erectile properties of the Rho-kinase inhibitor SAR407899 in diabetic animals and human isolated Corpora cavernosa. J. Transl. Med., 2012, 10(1), 59.
[http://dx.doi.org/10.1186/1479-5876-10-59] [PMID: 22444253]
[28]
Usta, M.F.; Sanabria, J.; Bivalacqua, T.J.; Hellstrom, W.J. Feline penile erection induced by topical glans penis application of combination alprostadil and SEPA (Topiglan). Int. J. Impot. Res., 2004, 16(1), 73-77.
[http://dx.doi.org/10.1038/sj.ijir.3901145] [PMID: 14963475]
[29]
Meadows, K.L.; Rushing, C.; Honeycutt, W.; Latta, K.; Howard, L.; Arrowood, C.A.; Niedzwiecki, D.; Hurwitz, H.I. Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: A pilot study. Support. Care Cancer, 2015, 23(5), 1311-1319.
[http://dx.doi.org/10.1007/s00520-014-2465-z] [PMID: 25341548]
[30]
Keating, G.M.; Scott, L.J. Vardenafil: A review of its use in erectile dysfunction. Drugs, 2003, 63(23), 2673-2703.
[http://dx.doi.org/10.2165/00003495-200363230-00010] [PMID: 14636086]
[31]
Mathers, M.J.; Klotz, T.; Brandt, A.S.; Roth, S.; Sommer, F. Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence. BJU Int., 2008, 101(9), 1129-1134.
[http://dx.doi.org/10.1111/j.1464-410X.2007.07376.x] [PMID: 18190629]
[32]
Vardi, Y.; Appel, B.; Ofer, Y.; Greunwald, I.; Dayan, L.; Jacob, G. Effect of chronic sildenafil treatment on penile endothelial function: A randomized, double-blind, placebo controlled study. J. Urol., 2009, 182(6), 2850-2855.
[http://dx.doi.org/10.1016/j.juro.2009.08.025] [PMID: 19837434]
[33]
Rosano, G.M.; Aversa, A.; Vitale, C.; Fabbri, A.; Fini, M.; Spera, G. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur. Urol., 2005, 47(2), 214-220.
[http://dx.doi.org/10.1016/j.eururo.2004.10.002] [PMID: 15661417]
[34]
Santi, D.; Granata, A.R.; Guidi, A.; Pignatti, E.; Trenti, T.; Roli, L.; Bozic, R.; Zaza, S.; Pacchioni, C.; Romano, S.; Nofer, J.R.; Rochira, V.; Carani, C.; Simoni, M. Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: A randomized, double-blind, prospective trial. Eur. J. Endocrinol., 2016, 174(4), 513-522.
[http://dx.doi.org/10.1530/EJE-15-1100] [PMID: 26792933]
[35]
Musicki, B.; Burnett, A.L. Endothelial dysfunction in diabetic erectile dysfunction. Int. J. Impot. Res., 2007, 19(2), 129-138.
[http://dx.doi.org/10.1038/sj.ijir.3901494] [PMID: 16775612]
[36]
Angulo, J.; González-Corrochano, R.; Cuevas, P.; Fernández, A.; La Fuente, J.M.; Rolo, F.; Allona, A.; Sáenz de Tejada, I. Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries. J. Sex. Med., 2010, 7(2 Pt 1), 758-768.
[http://dx.doi.org/10.1111/j.1743-6109.2009.01587.x] [PMID: 19912487]
[37]
Webb, D.J.; Muirhead, G.J.; Wulff, M.; Sutton, J.A.; Levi, R.; Dinsmore, W.W. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J. Am. Coll. Cardiol., 2000, 36(1), 25-31.
[http://dx.doi.org/10.1016/S0735-1097(00)00705-1] [PMID: 10898408]
[38]
Kloner, R.A.; Goggin, P.; Goldstein, I.; Hackett, G.; Kirby, M.G.; Osterloh, I.; Parker, J.D.; Sadovsky, R. A new perspective on the nitrate-phosphodiesterase type 5 inhibitor interaction. J. Cardiovasc. Pharmacol. Ther., 2018, 23(5), 375-386.
[http://dx.doi.org/10.1177/1074248418771896] [PMID: 29739235]
[39]
Christou, M.A.; Christou, P.A.; Markozannes, G.; Tsatsoulis, A.; Mastorakos, G.; Tigas, S. Effects of anabolic androgenic steroids on the reproductive system of athletes and recreational users: A systematic review and meta-analysis. Sports Med., 2017, 47(9), 1869-1883.
[http://dx.doi.org/10.1007/s40279-017-0709-z] [PMID: 28258581]
[40]
Aversa, A.; Isidori, A.M.; De Martino, M.U.; Caprio, M.; Fabbrini, E.; Rocchietti-March, M.; Frajese, G.; Fabbri, A. Androgens and penile erection: Evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin. Endocrinol. (Oxf.), 2000, 53(4), 517-522.
[http://dx.doi.org/10.1046/j.1365-2265.2000.01118.x] [PMID: 11012578]
[41]
Wessells, H.; Levine, N.; Hadley, M.E.; Dorr, R.; Hruby, V. Melanocortin receptor agonists, penile erection, and sexual motivation: Human studies with Melanotan II. Int. J. Impot. Res., 2000, 12(S4), S74-S79.
[http://dx.doi.org/10.1038/sj.ijir.3900582] [PMID: 11035391]
[42]
Anitha, B.; Inamadar, A.C.; Ragunatha, S. Finasteride-its impact on sexual function and prostate cancer. J. Cutan. Aesthet. Surg., 2009, 2(1), 12-16.
[http://dx.doi.org/10.4103/0974-2077.53093] [PMID: 20300365]
[43]
Heaton, J.P. Apomorphine: An update of clinical trial results. Int. J. Impot. Res., 2000, 12(S4), S67-S73.
[http://dx.doi.org/10.1038/sj.ijir.3900581] [PMID: 11035390]
[44]
Dula, E.; Keating, W.; Siami, P.F.; Edmonds, A.; O’neil, J.; Buttler, S. Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. Urology, 2000, 56(1), 130-135.
[http://dx.doi.org/10.1016/S0090-4295(00)00575-6] [PMID: 10869641]
[45]
Heaton, J.P. Characterising the benefit of apomorphine SL (Uprima) as an optimised treatment for representative populations with erectile dysfunction. Int. J. Impot. Res., 2001, 13(S3), S35-S39.
[http://dx.doi.org/10.1038/sj.ijir.3900721] [PMID: 11477490]
[46]
Dula, E.; Bukofzer, S.; Perdok, R.; George, M. Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction. Eur. Urol., 2001, 39(5), 558-3.
[http://dx.doi.org/10.1159/000052503] [PMID: 11464037]
[47]
Patel, M.V.; Kolasa, T.; Mortell, K.; Matulenko, M.A.; Hakeem, A.A.; Rohde, J.J.; Nelson, S.L.; Cowart, M.D.; Nakane, M.; Miller, L.N.; Uchic, M.E.; Terranova, M.A.; El-Kouhen, O.F.; Donnelly-Roberts, D.L.; Namovic, M.T.; Hollingsworth, P.R.; Chang, R.; Martino, B.R.; Wetter, J.M.; Marsh, K.C.; Martin, R.; Darbyshire, J.F.; Gintant, G.; Hsieh, G.C.; Moreland, R.B.; Sullivan, J.P.; Brioni, J.D.; Stewart, A.O. Discovery of 3-methyl-N-(1-oxy-3′,4′,5′,6′-tetrahydro-2‘H-[2,4’-bipyridine]-1′-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction. J. Med. Chem., 2006, 49(25), 7450-7465.
[http://dx.doi.org/10.1021/jm060662k] [PMID: 17149874]
[48]
Mydlo, J.H.; Volpe, M.A.; Macchia, R.J. Initial results utilizing combination therapy for patients with a suboptimal response to either alprostadil or sildenafil monotherapy. Eur. Urol., 2000, 38(1), 30-34.
[http://dx.doi.org/10.1159/000020248] [PMID: 10859438]
[49]
Lin, C.S.; Xin, Z.C.; Wang, Z.; Deng, C.; Huang, Y.C.; Lin, G.; Lue, T.F. Stem cell therapy for erectile dysfunction: A critical review. Stem Cells Dev., 2012, 21(3), 343-351.
[http://dx.doi.org/10.1089/scd.2011.0303] [PMID: 21793654]
[50]
Both, S. Recent developments in psychopharmaceutical approaches to treating female sexual interest and arousal disorder. Curr. Sex. Health Rep., 2017, 9(4), 192-199.
[http://dx.doi.org/10.1007/s11930-017-0124-3] [PMID: 29225554]
[51]
Cowart, M.; Latshaw, S.P.; Bhatia, P.; Daanen, J.F.; Rohde, J.; Nelson, S.L.; Patel, M.; Kolasa, T.; Nakane, M.; Uchic, M.E.; Miller, L.N.; Terranova, M.A.; Chang, R.; Donnelly-Roberts, D.L.; Namovic, M.T.; Hollingsworth, P.R.; Martino, B.R.; Lynch, J.J., III; Sullivan, J.P.; Hsieh, G.C.; Moreland, R.B.; Brioni, J.D.; Stewart, A.O. Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction. J. Med. Chem., 2004, 47(15), 3853-3864.
[http://dx.doi.org/10.1021/jm030505a] [PMID: 15239663]
[52]
Liu, J.; Zhou, F.; Li, G.Y.; Wang, L.; Li, H.X.; Bai, G.Y.; Guan, R.L.; Xu, Y.D.; Gao, Z.Z.; Tian, W.J.; Xin, Z.C. Evaluation of the effect of different doses of low energy shock wave therapy on the erectile function of streptozotocin (STZ)-induced diabetic rats. Int. J. Mol. Sci., 2013, 14(5), 10661-10673.
[http://dx.doi.org/10.3390/ijms140510661] [PMID: 23698784]
[53]
Melman, A.; Bar-Chama, N.; McCullough, A.; Davies, K.; Christ, G. hMaxi-K gene transfer in males with erectile dysfunction: Results of the first human trial. Hum. Gene Ther., 2006, 17(12), 1165-1176.
[http://dx.doi.org/10.1089/hum.2006.17.1165] [PMID: 17134370]
[54]
Bahk, J.Y.; Jung, J.H.; Han, H.; Min, S.K.; Lee, Y.S. Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: Preliminary report of 7 cases. Exp. Clin. Transplant., 2010, 8(2), 150-160.
[PMID: 20565373]
[55]
Kitrey, N.D.; Gruenwald, I.; Appel, B.; Shechter, A.; Massarwa, O.; Vardi, Y. Penile low intensity shock wave treatment is able to shift PDE5i nonresponders to responders: A double-blind, sham controlled study. J. Urol., 2016, 195(5), 1550-1555.
[http://dx.doi.org/10.1016/j.juro.2015.12.049] [PMID: 26694904]
[56]
Ciccone, M.M.; Notarnicola, A.; Scicchitano, P.; Sassara, M.; Carbonara, S.; Maiorano, M.; Moretti, B. Shockwave therapy in patients with peripheral artery disease. Adv. Ther., 2012, 29(8), 698-707.
[http://dx.doi.org/10.1007/s12325-012-0038-4] [PMID: 22869515]
[57]
Bogani, P.; Simonini, F.; Iriti, M.; Rossoni, M.; Faoro, F.; Poletti, A.; Visioli, F. Lepidium meyenii (Maca) does not exert direct androgenic activities. J. Ethnopharmacol., 2006, 104(3), 415-417.
[http://dx.doi.org/10.1016/j.jep.2005.09.028] [PMID: 16239088]
[58]
Rubio, J.; Riqueros, M.I.; Gasco, M.; Yucra, S.; Miranda, S.; Gonzales, G.F. Lepidium meyenii (Maca) reversed the lead acetate induced - damage on reproductive function in male rats. Food Chem. Toxicol., 2006, 44(7), 1114-1122.
[http://dx.doi.org/10.1016/j.fct.2006.01.007] [PMID: 16510228]
[59]
Gasco, M.; Aguilar, J.; Gonzales, G.F. Effect of chronic treatment with three varieties of Lepidium meyenii (Maca) on reproductive parameters and DNA quantification in adult male rats. Andrologia, 2007, 39(4), 151-158.
[http://dx.doi.org/10.1111/j.1439-0272.2007.00783.x] [PMID: 17683465]
[60]
Xin, Z.C.; Kim, E.K.; Lin, C.S.; Liu, W.J.; Tian, L.; Yuan, Y.M.; Fu, J. Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities. Asian J. Androl., 2003, 5(1), 15-18.
[PMID: 12646997]
[61]
Liu, W.J.; Xin, Z.C.; Xin, H.; Yuan, Y.M.; Tian, L.; Guo, Y.L. Effects of icariin on erectile function and expression of nitric oxide synthase isoforms in castrated rats. Asian J. Androl., 2005, 7(4), 381-388.
[http://dx.doi.org/10.1111/j.1745-7262.2005.00066.x] [PMID: 16281085]
[62]
Kim, H.J.; Woo, D.S.; Lee, G.; Kim, J.J. The relaxation effects of ginseng saponin in rabbit corporal smooth muscle: Is it a nitric oxide donor? Br. J. Urol., 1998, 82(5), 744-748.
[http://dx.doi.org/10.1046/j.1464-410X.1998.00811.x] [PMID: 9839593]
[63]
Zhang, H.; Zhou, Q.M.; Li, X.D.; Xie, Y.; Duan, X.; Min, F.L.; Liu, B.; Yuan, Z.G. Ginsenoside R(e) increases fertile and asthenozoospermic infertile human sperm motility by induction of nitric oxide synthase. Arch. Pharm. Res., 2006, 29(2), 145-151.
[http://dx.doi.org/10.1007/BF02974276] [PMID: 16526279]
[64]
Gauthaman, K.; Adaikan, P.G.; Prasad, R.N. Aphrodisiac properties of Tribulus terrestris extract (Protodioscin) in normal and castrated rats. Life Sci., 2002, 71(12), 1385-1396.
[http://dx.doi.org/10.1016/S0024-3205(02)01858-1] [PMID: 12127159]
[65]
Simonsen, U.; Prieto, D.; Hernández, M.; Sáenz de Tejada, I.; García-Sacristán, A. Prejunctional alpha 2-adrenoceptors inhibit nitrergic neurotransmission in horse penile resistance arteries. J. Urol., 1997, 157(6), 2356-2360.
[http://dx.doi.org/10.1016/S0022-5347(01)64780-3] [PMID: 9146670]
[66]
Chye, P.H. Traditional Asian folklore medicines in sexual health. Indian J. Urol., 2006, 22(3), 241-245.
[http://dx.doi.org/10.4103/0970-1591.27632]
[67]
Sambandan, T.G.; Rha, C.; Kadir, A.A. Bioactive fraction of Eurycoma longifolia. Patent No.: US 7132117 B2, 2006.
[68]
Tocharus, C.; Smitasiri, Y.; Jeenapongsa, R. Butea superba Roxb. enhances penile erection in rats. Phytother. Res., 2006, 20(6), 484-489.
[http://dx.doi.org/10.1002/ptr.1883] [PMID: 16619349]
[69]
Rakuambo, N.C.; Meyer, J.J.; Hussein, A.; Huyser, C.; Mdlalose, S.P.; Raidani, T.G. In vitro effect of medicinal plants used to treat erectile dysfunction on smooth muscle relaxation and human sperm. J. Ethnopharmacol., 2006, 105(1-2), 84-88.
[http://dx.doi.org/10.1016/j.jep.2005.10.008] [PMID: 16309865]

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy